There is a compelling need to develop biological marker(s) to confirm a clinical diagnosis of Alzheimer's disease (AD) during life in order to unequivocally identify AD patients for emerging therapeutic interventions. This review describes recent advances in the development of diagnostic marker(s) for AD, They include polymorphism of apolipoprotein E (ApoE) and α1-antichymotrypsin as well as cerebrospinal fluid (CSF) tau and CSF-amyloid β-protein levels, skin biopsy, and pupil dilatation assay by anti-cholinergic agent. In conclusion, ApoE genotyping should not be used as a sole diagnostic test for AD, and that monitoring of CSF-tau appeared to be most promising and reliable diagnostic aid. - Apolipoprotein E gene; cerebrospinal fluid; tau protein; α1-antichymotrypsin gene; pupil assay; Alzheimer's disease.
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)